|
KDM5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07019999995295E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.00630000000346E-05 |
| Normal-vs-Stage2 |
4.833300E-04 |
| Normal-vs-Stage3 |
1.72660999999685E-05 |
| Normal-vs-Stage4 |
6.85830000013432E-07 |
| Stage1-vs-Stage2 |
5.762000E-01 |
| Stage1-vs-Stage3 |
3.892000E-01 |
| Stage1-vs-Stage4 |
5.616000E-02 |
| Stage2-vs-Stage3 |
9.510400E-01 |
| Stage2-vs-Stage4 |
4.136600E-01 |
| Stage3-vs-Stage4 |
3.618800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54981999999082E-05 |
| Normal-vs-AfricanAmerican |
6.744200E-02 |
| Normal-vs-Asian |
2.47119999999823E-05 |
| Caucasian-vs-AfricanAmerican |
2.562400E-01 |
| Caucasian-vs-Asian |
3.994800E-01 |
| AfricanAmerican-vs-Asian |
9.192400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84420000054675E-07 |
| Normal-vs-Female |
1.7509299999996E-05 |
| Male-vs-Female |
2.598800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.180800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.58989999948989E-07 |
| Normal-vs-Age(61-80Yrs) |
2.04869999997914E-06 |
| Normal-vs-Age(81-100Yrs) |
1.724300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.880000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.319800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.385400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.675800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.568000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.670400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.337250E-01 |
| Classical-VS-Follicular |
6.357400E-04 |
| Classical-VS-Other |
8.919700E-02 |
| Classical-VS-Normal |
3.042800E-04 |
| Tall-VS-Follicular |
5.012000E-01 |
| Tall-VS-Other |
3.334800E-01 |
| Tall-VS-Normal |
2.245600E-04 |
| Follicular-VS-Other |
5.684400E-01 |
| Follicular-VS-Normal |
4.43840000308171E-08 |
| Other-VS-Normal |
2.604400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.12830000021225E-07 |
| Normal-vs-N1 |
6.46799999999281E-05 |
| N0-vs-N1 |
7.699600E-01 |
|
|
